Addressing the Analytical Gaps in Modern Therapeutic Development
Biopharmaceutical innovation is pushing boundaries with complex modalities like gene therapies and immune-modulating biologics, but traditional analytical methods often struggle to keep pace. Cell-based assays are becoming essential for characterizing these therapies, yet developing robust, context-specific solutions remains a challenge. Tailored strategies can help overcome key hurdles and generate regulatory-ready data to support next-generation therapeutic development.
We are tackling the key challenges of cell-based assay development such as biological variability, lack of context-specific tools, operational burden, and long-term continuity through integrated solutions that combine reporter gene technologies, custom cell line engineering, assay-ready formats, and secure cell banking. These strategies enable scalable, mechanism-driven assays that support reliable, regulatory-ready data across the development lifecycle.
Download the full application note to see how our cell-based products and services can streamline workflows and support regulatory-ready data generation.
Get exclusive insights from leading experts
Learn how industry leaders are applying cell-based technologies to meet the demands of complex biologics and regulatory standards.
What you'll learn:
- How engineered cell lines enhance biological relevance and assay precision
- Why assay-ready cells improve reproducibility and reduce cell culture workload
- How custom cell-based assay development supports advanced biologics
- How master cell banking ensures long-term assay stability and regulatory compliance
